Research/Areas of Interest

Our research centers on investigation of fundamental mechanisms of disease progression in prostate cancer linked to its metastatic phenotype and to develop novel experimental therapeutics to transform outcomes in the disease. Our studies have implicated .v and .5.1 integrins in the bone colonization process executed by disseminated prostate cancer cells. We have developed a proprietary bispecific antibody targeting these integrin-mediated tumor-stromal interactions. We are also interested in the role played by BCLXL in regulating PTEN-mutant prostate cancer cells.

Education

  • Doctor of Medicine, Lagos University, NGA, 1985
  • BS, University of Lagos, Nigeria